The performance of companies tied to Sildenafil's legacy presents a challenging investment scenario . While the initial surge generated substantial gains, generic copies have significantly eroded market https://socialdosa.com/story11666255/copyright-s-flagship-product-and-the-pharmaceutical-sector-a-uncertain-venture